A detailed history of Bank Of New Hampshire transactions in Johnson & Johnson stock. As of the latest transaction made, Bank Of New Hampshire holds 15,369 shares of JNJ stock, worth $2.22 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares
15,369
Previous 18,191 15.51%
Holding current value
$2.22 Million
Previous $2.66 Million 6.32%
% of portfolio
0.63%
Previous 0.69%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$145.48 - $167.38 $410,544 - $472,346
-2,822 Reduced 15.51%
15,369 $2.49 Million
Q2 2024

Jul 01, 2024

SELL
$144.38 - $157.78 $266,525 - $291,261
-1,846 Reduced 9.21%
18,191 $2.66 Million
Q1 2024

Apr 10, 2024

SELL
$155.22 - $162.74 $189,678 - $198,868
-1,222 Reduced 5.75%
20,037 $3.17 Million
Q4 2023

Feb 02, 2024

SELL
$145.6 - $158.88 $1.2 Million - $1.31 Million
-8,231 Reduced 27.91%
21,259 $3.33 Million
Q3 2023

Oct 10, 2023

SELL
$155.75 - $174.48 $86,129 - $96,487
-553 Reduced 1.84%
29,490 $4.59 Million
Q2 2023

Jul 28, 2023

BUY
$154.35 - $166.11 $11,730 - $12,624
76 Added 0.25%
30,043 $4.97 Million
Q1 2023

Apr 04, 2023

SELL
$151.05 - $180.26 $146,971 - $175,392
-973 Reduced 3.14%
29,967 $4.64 Million
Q4 2022

Jan 10, 2023

SELL
$160.2 - $179.79 $134,888 - $151,383
-842 Reduced 2.65%
30,940 $5.47 Million
Q3 2022

Oct 24, 2022

SELL
$161.33 - $179.52 $22,586 - $25,132
-140 Reduced 0.44%
31,782 $5.19 Million
Q2 2022

Jul 08, 2022

SELL
$168.19 - $186.01 $153,725 - $170,013
-914 Reduced 2.78%
31,922 $5.67 Million
Q1 2022

Apr 20, 2022

SELL
$158.14 - $179.59 $80,335 - $91,231
-508 Reduced 1.52%
32,836 $5.82 Million
Q4 2021

Jan 12, 2022

BUY
$155.93 - $173.01 $733,026 - $813,320
4,701 Added 16.41%
33,344 $5.7 Million
Q2 2021

Jul 06, 2021

BUY
$159.48 - $171.07 $4.57 Million - $4.9 Million
28,643 New
28,643 $4.72 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $378B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Bank Of New Hampshire Portfolio

Follow Bank Of New Hampshire and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New Hampshire, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New Hampshire with notifications on news.